Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Orca Bio
Fierce Pharma
Orca rides $250M funding wave toward cancer cell therapy launch
Orca disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for commercialization of a cancer cell therapy.
Nick Paul Taylor
Jan 9, 2026 11:19am
How Nobel-winning cells could become a 'universal drug'
Oct 21, 2025 2:00pm
Protara gears up for next commercial steps—Chutes & Ladders
Jun 6, 2025 8:30am
Orca prepares to make market plunge after phase 3 win
Mar 17, 2025 7:00am
Orca Bio, Lyell pen new pact to open up CAR-T for solid tumors
Sep 2, 2020 8:30am
Orca Bio breaches the surface with $192M
Jun 17, 2020 7:00am
